BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15610846)

  • 1. Engineered biosynthesis of geldanamycin analogs for Hsp90 inhibition.
    Patel K; Piagentini M; Rascher A; Tian ZQ; Buchanan GO; Regentin R; Hu Z; Hutchinson CR; McDaniel R
    Chem Biol; 2004 Dec; 11(12):1625-33. PubMed ID: 15610846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational biosynthetic engineering for optimization of geldanamycin analogues.
    Kim W; Lee D; Hong SS; Na Z; Shin JC; Roh SH; Wu CZ; Choi O; Lee K; Shen YM; Paik SG; Lee JJ; Hong YS
    Chembiochem; 2009 May; 10(7):1243-51. PubMed ID: 19308924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of 8-demethylgeldanamycin and 4,5-epoxy-8-demethylgeldanamycin from a recombinant strain of Streptomyces hygroscopicus.
    Buchanan GO; Regentin R; Piagentini M; Rascher A; McDaniel R; Galazzo JL; Licari PJ
    J Nat Prod; 2005 Apr; 68(4):607-10. PubMed ID: 15844961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activities of novel 17-aminogeldanamycin derivatives.
    Tian ZQ; Liu Y; Zhang D; Wang Z; Dong SD; Carreras CW; Zhou Y; Rastelli G; Santi DV; Myles DC
    Bioorg Med Chem; 2004 Oct; 12(20):5317-29. PubMed ID: 15388159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New non-quinone geldanamycin analogs from genetically engineered Streptomyces hygroscopicus.
    Wu CZ; Moon AN; Jang JH; Lee D; Kang SY; Park JT; Ahn JS; Hwang BY; Kim YH; Lee HS; Hong YS
    J Antibiot (Tokyo); 2011 Jun; 64(6):461-3. PubMed ID: 21448187
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of tailoring genes involved in the modification of geldanamycin polyketide in Streptomyces hygroscopicus JCM4427.
    Shin JC; Na Z; Lee DH; Kim WC; Lee K; Shen YM; Paik SG; Hong YS; Lee JJ
    J Microbiol Biotechnol; 2008 Jun; 18(6):1101-8. PubMed ID: 18600054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models.
    Smith V; Sausville EA; Camalier RF; Fiebig HH; Burger AM
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):126-37. PubMed ID: 15841378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the carbamoyltransferase gene refines post-polyketide synthase modification steps in the biosynthesis of the antitumor agent geldanamycin.
    Hong YS; Lee D; Kim W; Jeong JK; Kim CG; Sohng JK; Lee JH; Paik SG; Lee JJ
    J Am Chem Soc; 2004 Sep; 126(36):11142-3. PubMed ID: 15355082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites.
    Lee K; Ryu JS; Jin Y; Kim W; Kaur N; Chung SJ; Jeon YJ; Park JT; Bang JS; Lee HS; Kim TY; Lee JJ; Hong YS
    Org Biomol Chem; 2008 Jan; 6(2):340-8. PubMed ID: 18175003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of a new class of geldanamycin derivatives as potent inhibitors of Hsp90.
    Le Brazidec JY; Kamal A; Busch D; Thao L; Zhang L; Timony G; Grecko R; Trent K; Lough R; Salazar T; Khan S; Burrows F; Boehm MF
    J Med Chem; 2004 Jul; 47(15):3865-73. PubMed ID: 15239664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent cytotoxic C-11 modified geldanamycin analogues.
    Tian ZQ; Wang Z; MacMillan KS; Zhou Y; Carreras CW; Mueller T; Myles DC; Liu Y
    J Med Chem; 2009 May; 52(10):3265-73. PubMed ID: 19405528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
    Onodera H; Kaneko M; Takahashi Y; Uochi Y; Funahashi J; Nakashima T; Soga S; Suzuki M; Ikeda S; Yamashita Y; Rahayu ES; Kanda Y; Ichimura M
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1588-91. PubMed ID: 18243703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroquinone ansamycins: toward resolving the conflict between low in vitro affinity and high cellular potency of geldanamycin derivatives.
    Maroney AC; Marugan JJ; Mezzasalma TM; Barnakov AN; Garrabrant TA; Weaner LE; Jones WJ; Barnakova LA; Koblish HK; Todd MJ; Masucci JA; Deckman IC; Galemmo RA; Johnson DL
    Biochemistry; 2006 May; 45(17):5678-85. PubMed ID: 16634649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
    Schwock J; Pham NA; Cao MP; Hedley DW
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of putative PKS genes can double geldanamycin yield in Streptomyces hygroscopicus 17997.
    Li YH; Li M; He WQ; Wang YG; Shao RG
    Genet Mol Res; 2013 Jun; 12(2):2076-85. PubMed ID: 23913387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment of gene transduction system in geldanamycin producer - Streptomyces hygroscopicus 17997 and its application for gene disruption experiment].
    Gao HY; Wang YG; Gao QJ; Shang GD; Sun GZ; Yang Y
    Sheng Wu Gong Cheng Xue Bao; 2003 Jul; 19(4):407-11. PubMed ID: 15969055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heat shock protein 90: novel target for cancer therapy].
    Chen Y; Ding J
    Ai Zheng; 2004 Aug; 23(8):968-74. PubMed ID: 15301726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New, non-quinone fluorogeldanamycin derivatives strongly inhibit Hsp90.
    Hermane J; Bułyszko I; Eichner S; Sasse F; Collisi W; Poso A; Schax E; Walter JG; Scheper T; Kock K; Herrmann C; Aliuos P; Reuter G; Zeilinger C; Kirschning A
    Chembiochem; 2015 Jan; 16(2):302-11. PubMed ID: 25572106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of 7-carbamate analogs of geldanamycin.
    Rastelli G; Tian ZQ; Wang Z; Myles D; Liu Y
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5016-21. PubMed ID: 16165354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90.
    Sydor JR; Normant E; Pien CS; Porter JR; Ge J; Grenier L; Pak RH; Ali JA; Dembski MS; Hudak J; Patterson J; Penders C; Pink M; Read MA; Sang J; Woodward C; Zhang Y; Grayzel DS; Wright J; Barrett JA; Palombella VJ; Adams J; Tong JK
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17408-13. PubMed ID: 17090671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.